Contribution of N-linked glycans on HSV-2 gB to cell-cell fusion and viral entry

Virology

Volumn 483, Issue , 2015, Pages 72-82

  Luo, Sukun ^a,b   Hu, Kai ^a   He, Siyi ^a,b   Wang, Ping ^a,b   Zhang, Mudan ^a,b   Huang, Xin ^a,b   Du, Tao ^a   Zheng, Chunfu ^c   Liu, Yalan ^a   Hu, Qinxue ^a,d  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c SOOCHOW UNIVERSITY   (China)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Fusion; GB; HSV 2; N linked glycan; Viral entry

Indexed keywords

GLYCAN DERIVATIVE; GLYCOPROTEIN; GLYCOPROTEIN B; GLYCOPROTEIN D; GLYCOPROTEIN H; GLYCOPROTEIN L; N LINKED GLYCAN DERIVATIVE; UNCLASSIFIED DRUG; GLYCOPROTEIN B, HERPES SIMPLEX VIRUS TYPE 2; POLYSACCHARIDE; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; CELL FUSION; CELL VACUOLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HERPES SIMPLEX VIRUS 2; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SITE DIRECTED MUTAGENESIS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS MUTATION; VIRUS PARTICLE; ANIMAL; CELL LINE; CHEMISTRY; DNA SEQUENCE; GENETICS; HUMAN; MISSENSE MUTATION; MOLECULAR GENETICS; PHYSIOLOGY;

HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMALS; CELL FUSION; CELL LINE; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; HERPESVIRUS 2, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POLYSACCHARIDES; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84928947736     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.04.005     Document Type: Article

References (85)

1. Aguilar H.C., Matreyek K.A., Filone C.M., Hashimi S.T., Levroney E.L., Negrete O.A., Bertolotti-Ciarlet A., Choi D.Y., McHardy I., Fulcher J.A., Su S.V., Wolf M.C., Kohatsu L., Baum L.G., Lee B. N-glycans on nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J. Virol. 2006, 80(10):4878-4889.
2. Akhtar J., Shukla D. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J. 2009, 276(24):7228-7236.
3. Arii J., Goto H., Suenaga T., Oyama M., Kozuka-Hata H., Imai T., Minowa A., Akashi H., Arase H., Kawaoka Y., Kawaguchi Y. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature 2010, 467(7317):859-862.
4. Arii J., Uema M., Morimoto T., Sagara H., Akashi H., Ono E., Arase H., Kawaguchi Y. Entry of herpes simplex virus 1 and other alphaherpesviruses via the paired immunoglobulin-like type 2 receptor α. J. Virol. 2009, 83(9):4520-4527.
5. Arii J., Wang J., Morimoto T., Suenaga T., Akashi H., Arase H., Kawaguchi Y. A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor {alpha} (PILR{alpha}) abrogates PILR{alpha}-dependent viral entry and reduces pathogenesis. J. Virol. 2010, 84(20):10773-10783.
6. Atanasiu D., Saw W.T., Cohen G.H., Eisenberg R.J. Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB. J. Virol. 2010, 84(23):12292-12299.
7. Atanasiu D., Whitbeck J.C., Cairns T.M., Reilly B., Cohen G.H., Eisenberg R.J. Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion. Proc. Natl. Acad. Sci. USA 2007, 104(47):18718-18723.
8. Atanasiu D., Whitbeck J.C., de Leon M.P., Lou H., Hannah B.P., Cohen G.H., Eisenberg R.J. Bimolecular complementation defines functional regions of herpes simplex virus gB that are involved with gH/gL as a necessary step leading to cell fusion. J. Virol. 2010, 84(8):3825-3834.
9. Balzarini J. Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat. Rev. Microbiol. 2007, 5(8):583-597.
10. Bause E. Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes. Biochem. J. 1983, 209(2):331-336.
11. Bause E., Legler G. The role of the hydroxy amino acid in the triplet sequence Asn-Xaa-Thr(Ser) for the N-glycosylation step during glycoprotein biosynthesis. Biochem. J. 1981, 195(3):639-644.
12. Beitia Ortiz de Zarate I., Cantero-Aguilar L., Longo M., Berlioz-Torrent C., Rozenberg F. Contribution of endocytic motifs in the cytoplasmic tail of herpes simplex virus type 1 glycoprotein B to virus replication and cell-cell fusion. J. Virol. 2007, 81(24):13889-13903.
13. Beitia Ortiz de Zarate I., Kaelin K., Rozenberg F. Effects of mutations in the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B on intracellular transport and infectivity. J. Virol. 2004, 78(3):1540-1551.
14. Bender F.C., Samanta M., Heldwein E.E., de Leon M.P., Bilman E., Lou H., Whitbeck J.C., Eisenberg R.J., Cohen G.H. Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions. J. Virol. 2007, 81(8):3827-3841.
15. Bender F.C., Whitbeck J.C., Lou H., Cohen G.H., Eisenberg R.J. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry. J. Virol. 2005, 79(18):11588-11597.
16. Biering S.B., Huang A., Vu A.T., Robinson L.R., Bradel-Tretheway B., Choi E., Lee B., Aguilar H.C. N-glycans on the nipah virus attachment glycoprotein modulate fusion and viral entry as they protect against antibody neutralization. J. Virol. 2012, 86(22):11991-12002.
17. Binley J.M., Ban Y.-E.A., Crooks E.T., Eggink D., Osawa K., Schief W.R., Sanders R.W. Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization. J. Virol. 2010, 84(11):5637-5655.
18. Calistri A., Sette P., Salata C., Cancellotti E., Forghieri C., Comin A., Göttlinger H., Campadelli-Fiume G., Palù G., Parolin C. Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies. J. Virol. 2007, 81(20):11468-11478.
19. Campadelli-Fiume G., Cocchi F., Menotti L., Lopez M. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev. Med. Virol. 2000, 10(5):305-319.
20. Cheshenko N., Herold B.C. Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spread. J. Gen. Virol. 2002, 83(Pt 9):2247-2255.
21. Chouljenko V.N., Iyer A.V., Chowdhury S., Chouljenko D.V., Kousoulas K.G. The amino terminus of herpes simplex virus type 1 glycoprotein K (gK) modulates gB-mediated virus-induced cell fusion and virion egress. J. Virol. 2009, 83(23):12301-12313.
22. Chouljenko V.N., Iyer A.V., Chowdhury S., Kim J., Kousoulas K.G. The herpes simplex virus type 1 UL20 protein and the amino terminus of glycoprotein K (gK) physically interact with gB. J. Virol. 2010, 84(17):8596-8606.
23. Chowdary T.K., Heldwein E.E. Syncytial phenotype of C-terminally truncated herpes simplex virus type 1 gB is associated with diminished membrane interactions. J. Virol. 2010, 84(10):4923-4935.
24. Chowdhury S., Chouljenko V.N., Naderi M., Kousoulas K.G. The amino terminus of herpes simplex virus 1 glycoprotein K is required for virion entry via the paired immunoglobulin-like type-2 receptor alpha. J. Virol. 2013, 87(6):3305-3313.
25. Connolly S.A., Longnecker R. Residues within the C-terminal arm of the herpes simplex virus type 1 glycoprotein B ectodomain contribute to its refolding during the fusion step of virus entry. J. Virol. 2012, 86(12):6386-6393.
26. de Jong M.A.W.P., de Witte L., Bolmstedt A., van Kooyk Y., Geijtenbeek T.B.H. Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN. J. Gen. Virol. 2008, 89(Pt 10):2398-2409.
27. Doms R.W., Lamb R.A., Rose J.K., Helenius A. Folding and assembly of viral membrane proteins. Virology 1993, 193(2):545-562.
28. Drummer H.E., Hill M.K., Maerz A.L., Wood S., Ramsland P.A., Mak J., Poumbourios P. Allosteric Modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity. PLoS Pathog. 2013, 9(4):e1003218.
29. Fan J., Liu Y., Yuan Z. Critical role of dengue virus NS1 protein in viral replication. Virol. Sin. 2014, 29(3):162-169.
30. Fan Z., Grantham M.L., Smith M.S., Anderson E.S., Cardelli J.A., Muggeridge M.I. Truncation of herpes simplex virus type 2 glycoprotein B increases its cell surface expression and activity in cell-cell fusion, but these properties are unrelated. J. Virol. 2002, 76(18):9271-9283.
31. Fenouillet E., Jones I., Powell B., Schmitt D., Kieny M.P., Gluckman J.C. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain. J. Virol. 1993, 67(1):150-160.
32. Glorioso J., Szczesiul M.S., Marlin S.D., Levine M. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane. Virology 1983, 126(1):1-18.
33. Hannah B.P., Cairns T.M., Bender F.C., Whitbeck J.C., Lou H., Eisenberg R.J., Cohen G.H. Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops. J. Virol. 2009, 83(13):6825-6836.
34. Hebert D.N., Zhang J.X., Chen W., Foellmer B., Helenius A. The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J. Cell Biol. 1997, 139(3):613-623.
35. Heldwein E.E., Krummenacher C. Entry of herpesviruses into mammalian cells. Cell Mol. Life Sci. 2008, 65(11):1653-1668.
36. Heldwein E.E., Lou H., Bender F.C., Cohen G.H., Eisenberg R.J., Harrison S.C. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 2006, 313(5784):217-220.
37. Herold B.C., Visalli R.J., Susmarski N., Brandt C.R., Spear P.G. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J. Gen. Virol. 1994, 75(Pt 6):1211-1222.
38. Hu Q.-X., Barry A.P., Wang Z.-X., Connolly S.M., Peiper S.C., Greenberg M.L. Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis. J. Virol. 2000, 74(24):11858-11872.
39. Huang W., Hu K., Luo S., Zhang M., Li C., Jin W., Liu Y., Griffin G.E., Shattock R.J., Hu Q. Herpes simplex virus type 2 infection of human epithelial cells induces CXCL9 expression and CD4+ T cell migration via activation of p38-CCAAT/enhancer-binding protein-β pathway. J. Immunol. 2012, 188(12):6247-6257.
40. Huang X., Jin W., Griffin G.E., Shattock R.J., Hu Q. Removal of two high-mannose N-linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate-binding agent griffithsin. J. Gen. Virol. 2011, 92(Pt 10):2367-2373.
41. Huang X., Jin W., Hu K., Luo S., Du T., Griffin G.E., Shattock R.J., Hu Q. Highly conserved HIV-1 gp120 glycans proximal to CD4-binding region affect viral infectivity and neutralizing antibody induction. Virology 2012, 423(1):97-106.
42. Kasturi L., Eshleman J.R., Wunner W.H., Shakin-Eshleman S.H. The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein. J. Biol. Chem. 1995, 270(24):14756-14761.
43. Kim I.-J., Chouljenko V.N., Walker J.D., Kousoulas K.G. Herpes simplex virus type 1 (HSV-1) glycoprotein M (gM) and the membrane associated protein UL11 are required for virus-induced cell fusion and efficient virus entry. J. Virol. 2013, 87(14):8029-8037.
44. Kobayashi Y., Suzuki Y. Evidence for N-Glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin. J. Virol. 2012, 86(7):3446-3451.
45. Krummenacher C., Supekar V.M., Whitbeck J.C., Lazear E., Connolly S.A., Eisenberg R.J., Cohen G.H., Wiley D.C., Carfi A. Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry. EMBO J. 2005, 24(23):4144-4153.
46. Kuklin N., Daheshia M., Karem K., Manickan E., Rouse B.T. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 1997, 71(4):3138-3145.
47. Laquerre S., Argnani R., Anderson D.B., Zucchini S., Manservigi R., Glorioso J.C. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J. Virol. 1998, 72(7):6119-6130.
48. Lazear E., Carfi A., Whitbeck J.C., Cairns T.M., Krummenacher C., Cohen G.H., Eisenberg R.J. Engineered disulfide bonds in herpes simplex virus type 1 gD separate receptor binding from fusion initiation and viral entry. J. Virol. 2008, 82(2):700-709.
49. Li W., Minova-Foster T.J., Norton D.D., Muggeridge M.I. Identification of functional domains in herpes simplex Virus 2 glycoprotein B. J. Virol. 2006, 80(8):3792-3800.
50. Li Y., Wang S., Zhu H., Zheng C. Cloning of the herpes simplex virus type 1 genome as a novel luciferase-tagged infectious bacterial artificial chromosome. Arch. Virol. 2011, 156(12):2267-2272.
51. Lin E., Spear P.G. Random linker-insertion mutagenesis to identify functional domains of herpes simplex virus type 1 glycoprotein B. Proc. Natl. Acad. Sci. USA 2007, 104(32):13140-13145.
52. Looker K.J., Garnett G.P., Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull. World Health Organ. 2008, 86(10):805-812. A.
53. Maggioni C., Braakman I. Synthesis and quality control of viral membrane proteins. Curr. Top. Microbiol. Immunol. 2005, 285:175-198.
54. Manoj S., Jogger C.R., Myscofski D., Yoon M., Spear P.G. Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism. Proc. Natl. Acad. Sci. USA 2004, 101(34):12414-12421.
55. Martinelli E., Tharinger H., Frank I., Arthos J., Piatak M., Lifson J.D., Blanchard J., Gettie A., Robbiani M. HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. PLoS Pathog. 2011, 7(6):e1002109.
56. Melikyan G.B., Markosyan R.M., Hemmati H., Delmedico M.K., Lambert D.M., Cohen F.S. Evidence that the transition of HIV-1 Gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J. Cell Biol. 2000, 151(2):413-424.
57. Muggeridge M.I. Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells. J. Gen. Virol. 2000, 81(Pt 8):2017-2027.
58. Ohuchi M., Ohuchi R., Feldmann A., Klenk H.D. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J. Virol. 1997, 71(11):8377-8384.
59. Ohuchi R., Ohuchi M., Garten W., Klenk H.D. Oligosaccharides in the stem region maintain the influenza virus hemagglutinin in the metastable form required for fusion activity. J. Virol. 1997, 71(5):3719-3725.
60. Papworth M.A., Van Dijk A.A., Benyon G.R., Allen T.D., Arrand J.R., Mackett M. The processing, transport and heterologous expression of Epstein-Barr virus gp110. J. Gen. Virol. 1997, 78(Pt 9):2179-2189.
61. Pikora C., Wittish C., Desrosiers R.C. Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4. J Virol. 2005, 79(19):12575-12583.
62. Rosnoblet C., Peanne R., Legrand D., Foulquier F. Glycosylation disorders of membrane trafficking. Glycoconj J. 2013, 30(1):23-31.
63. Roth J. Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. Chem. Rev. 2002, 102(2):285-303.
64. Russell C.J., Jardetzky T.S., Lamb R.A. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J. 2001, 20(15):4024-4034.
65. Satoh T., Arii J., Suenaga T., Wang J., Kogure A., Uehori J., Arase N., Shiratori I., Tanaka S., Kawaguchi Y., Spear P.G., Lanier L.L., Arase H. PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 2008, 132(6):935-944.
66. Sharan S.K., Thomason L.C., Kuznetsov S.G., Court D.L. Recombineering: a homologous recombination-based method of genetic engineering. Nat. Protoc. 2009, 4(2):206-223.
67. Shirato K., Miyoshi H., Goto A., Ako Y., Ueki T., Kariwa H., Takashima I. Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. J. Gen. Virol. 2004, 85(Pt 12):3637-3645.
68. Shukla D., Spear P.G. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 2001, 108(4):503-510.
69. Sodora D.L., Cohen G.H., Muggeridge M.I., Eisenberg R.J. Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein. J. Virol. 1991, 65(8):4424-4431.
70. Sodora D.L., Eisenberg R.J., Cohen G.H. Characterization of a recombinant herpes simplex virus which expresses a glycoprotein D lacking asparagine-linked oligosaccharides. J. Virol. 1991, 65(8):4432-4441.
71. Sommer M., Courtney R.J. Differential rates of processing and transport of herpes simplex virus type 1 glycoproteins gB and gC. J Virol. 1991, 65(1):520-525.
72. Stampfer S.D., Lou H., Cohen G.H., Eisenberg R.J., Heldwein E.E. Structural basis of local, pH-dependent conformational changes in glycoprotein B from herpes simplex virus type 1. J. Virol. 2010, 84(24):12924-12933.
73. Suenaga T., Satoh T., Somboonthum P., Kawaguchi Y., Mori Y., Arase H. Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc. Natl. Acad. Sci. USA 2010, 107(2):866-871.
74. Sugimoto K., Uema M., Sagara H., Tanaka M., Sata T., Hashimoto Y., Kawaguchi Y. Simultaneous tracking of capsid, tegument, and envelope protein localization in living cells infected with triply fluorescent herpes simplex Virus 1. J. Virol. 2008, 82(11):5198-5211.
75. Tan D.H., Murphy K., Shah P., Walmsley S.L. Herpes simplex virus type 2 and HIV disease progression: a systematic review of observational studies. BMC Infect. Dis. 2013, 13:502.
76. Terence P., McDonalda C.E.J., Lia Ping, Rixona Helen W.McL., Browna Gaie, Aitkenc James D., MacLellana Kirsty, Sugruea Richard J. Evidence that maturation of the N-linked glycans of the respiratory syncytial virus (RSV) glycoproteins is required for virus-mediated cell fusion: the effect of α-mannosidase inhibitors on RSV infectivity. Virology 2006, 350(2):289-301.
77. Turcotte S., Letellier J., Lippé R. Herpes simplex virus type 1 capsids transit by the trans-golgi network, where viral glycoproteins accumulate independently of capsid egress. J. Virol. 2005, 79(14):8847-8860.
78. Turner A., Bruun B., Minson T., Browne H. Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J. Virol. 1998, 72(1):873-875.
79. Uchida H., Chan J., Goins W.F., Grandi P., Kumagai I., Cohen J.B., Glorioso J.C. A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus Type 1 infection. J. Virol. 2010, 84(23):12200-12209.
80. Vigerust D.J., Shepherd V.L. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 2007, 15(5):211-218.
81. Vu H.L., Kwon B., Yoon K.J., Laegreid W.W., Pattnaik A.K., Osorio F.A. Immune evasion of porcine reproductive and respiratory syndrome virus through glycan shielding involves both glycoprotein 5 as well as glycoprotein 3. J. Virol. 2011, 85(11):5555-5564.
82. Wang J., Fan Q., Satoh T., Arii J., Lanier L.L., Spear P.G., Kawaguchi Y., Arase H. Binding of herpes simplex virus glycoprotein B (gB) to paired immunoglobulin-like type 2 Receptor {alpha} depends on specific sialylated O-Linked Glycans on gB. J. Virol. 2009, 83(24):13042-13045.
83. Wisner T.W., Johnson D.C. Redistribution of cellular and herpes simplex virus proteins from the trans-golgi network to cell junctions without enveloped capsids. J. Virol. 2004, 78(21):11519-11535.
84. Yuste E., Bixby J., Lifson J., Sato S., Johnson W., Desrosiers R. Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies. J. Virol. 2008, 82(24):12472-12486.
85. Zhu J., Hladik F., Woodward A., Klock A., Peng T., Johnston C., Remington M., Magaret A., Koelle D.M., Wald A., Corey L. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 2009, 15(8):886-892.